We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On November 19, 2010, the Federal Court Appeal dismissed an appeal by Glaxo Group Limited ("Glaxo") from a decision of the Federal Court expunging its trade-mark for the shape and colour of its ADVAIR DISKUS inhaler
